Our Pricing

Wegovy UK Pricing: Private Prescription from £79.00

Published on: June 03, 2026

Understanding wegovy uk pricing private prescription options helps you make informed decisions about weight management treatment. At Cured Pharmacy, we offer transparent upfront pricing starting from £79.00, with all costs clearly displayed before your free online consultation with UK-registered prescribers.

How Wegovy Pricing Works in the UK

Wegovy (semaglutide) is a prescription-only medication licensed by the MHRA for chronic weight management in adults with a BMI of 30 kg/m² or above, or 27 kg/m² with weight-related health conditions [1]. Private prescription costs vary based on the dose strength prescribed by your UK clinician, which follows a structured escalation protocol over 16-20 weeks.

At Cured Pharmacy, our wegovy uk pricing private prescription model includes the medication, clinical consultation, prescriber review, and discreet delivery to your door. Unlike some providers who add hidden consultation fees or subscription charges, our pricing is transparent from the outset — you'll see the exact cost before completing your medical assessment.

The graduated dosing schedule means you'll start with a lower-strength pen (0.25mg weekly) and increase gradually to the maintenance dose (2.4mg weekly) as your body adapts [2]. This clinically proven approach minimises gastrointestinal side effects whilst optimising weight loss outcomes.

What's Included in Your Wegovy Private Prescription

Your private prescription from Cured Pharmacy includes comprehensive clinical support throughout your weight management journey. Each package contains a pre-filled Wegovy FlexTouch pen with four single-dose injections, detailed administration instructions, and access to our UK-registered clinical team for ongoing queries.

The free online consultation takes under three minutes and is reviewed by a GMC-registered prescriber who assesses your medical history, current medications, and suitability for semaglutide therapy. Subject to prescriber approval, your medication is dispensed from our GPhC-registered pharmacy (9012511) and delivered in 100% discreet packaging with tracked courier service.

Superintendent pharmacist Tarun Kumar (GPhC 2233073) oversees all clinical protocols, ensuring every prescription meets UK regulatory standards and patient safety requirements. We source only genuine UK-licensed Wegovy pens manufactured by Novo Nordisk — never grey market imports or compounded alternatives.

Transparent Pricing Before You Commit

Unlike traditional pharmacy models where pricing remains unclear until after consultation, we display all costs upfront on our product pages. This transparency allows you to budget effectively and compare wegovy price uk pharmacy options without obligation. If your prescriber determines Wegovy isn't clinically appropriate, you won't be charged — we only process payment when a prescription is issued and medication dispensed.

Clinical Evidence Behind Wegovy's Effectiveness

Wegovy's active ingredient, semaglutide, demonstrated remarkable efficacy in the landmark STEP clinical trial programme involving over 4,500 participants across multiple studies [2]. In the STEP 1 trial, adults receiving semaglutide 2.4mg weekly achieved an average 14.9% body weight reduction over 68 weeks, compared to 2.4% with placebo [2].

The medication works by mimicking GLP-1, a naturally occurring hormone that regulates appetite and food intake. By activating GLP-1 receptors in the brain, Wegovy reduces hunger signals, increases feelings of fullness, and helps patients adhere to reduced-calorie diets more successfully [3]. This mechanism addresses the biological drivers of weight regain that often undermine traditional diet-and-exercise approaches.

NICE guidelines recognise semaglutide as a clinically effective option for weight management when prescribed alongside lifestyle interventions [4]. The treatment is most effective when combined with a structured nutrition programme and increased physical activity — your prescriber will provide personalised guidance on optimising these complementary strategies.

Expected Timeline for Results

Most patients begin noticing appetite reduction within the first 2-4 weeks of treatment, with measurable weight loss typically evident by week 8-12 [2]. The dose escalation protocol means maximum efficacy occurs once you reach the 2.4mg maintenance dose, usually after 16-20 weeks of treatment. Clinical trials showed continued weight loss through 68 weeks, with many patients maintaining reduced weight beyond the trial period when treatment continued [2].

Comparing Wegovy UK Pricing Across Treatment Options

When evaluating wegovy cost uk private options, it's essential to consider the complete value proposition rather than price alone. Factors including clinical support quality, prescriber qualifications, medication authenticity, and delivery reliability all impact your treatment experience and outcomes.

At Cured Pharmacy, we guarantee the lowest prices in the UK for genuine, licensed weight management medications. Our streamlined online model eliminates traditional pharmacy overheads, allowing us to pass savings directly to patients whilst maintaining the highest clinical and regulatory standards.

Some providers advertise lower initial prices but add consultation fees, subscription charges, or mandatory follow-up appointments that increase total treatment costs. We believe in transparent pricing — the amount shown on our product page is what you pay, with no hidden extras or recurring subscriptions unless you choose to continue treatment.

Who Can Access Private Wegovy Prescriptions

Wegovy is licensed in the UK for adults with a BMI of 30 kg/m² or higher, or 27 kg/m² or higher with at least one weight-related comorbidity such as type 2 diabetes, hypertension, or obstructive sleep apnoea [1]. Your prescriber will calculate your BMI during the online consultation and assess whether you meet clinical criteria for treatment.

Certain medical conditions and medications may contraindicate Wegovy use. The medication is not suitable for patients with personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, or severe gastrointestinal disease [1]. Pregnant or breastfeeding women should not use Wegovy, and treatment should be discontinued at least two months before planned pregnancy.

Our UK prescribers conduct thorough medication reviews to identify potential interactions with your current prescriptions. Semaglutide can delay gastric emptying, which may affect absorption of oral medications — particularly important for time-sensitive drugs like contraceptives or thyroid hormones. Your clinician will provide specific guidance if adjustments are needed.

Starting Your Wegovy Assessment

The online consultation process at Cured Pharmacy takes less than three minutes and covers your medical history, current health status, and weight management goals. You'll provide information about previous weight loss attempts, existing medical conditions, and any medications you currently take. A UK-registered prescriber reviews your responses within hours, and if approved, your medication ships the same day for next-day delivery across most of the UK.

Managing Side Effects and Treatment Expectations

The most common side effects of Wegovy are gastrointestinal, including nausea, diarrhoea, constipation, and vomiting, particularly during the dose escalation phase [1]. These effects typically diminish as your body adapts to each new dose level — the gradual titration schedule specifically aims to minimise discomfort whilst building therapeutic levels.

To reduce gastrointestinal symptoms, eat smaller, more frequent meals, avoid high-fat foods, and stay well-hydrated throughout treatment. If side effects become problematic, contact our clinical team — your prescriber may recommend staying at your current dose longer before escalating, or adjusting the timing of your weekly injection.

Serious side effects are rare but require immediate medical attention. These include severe abdominal pain (potential pancreatitis), vision changes, persistent vomiting, or signs of allergic reaction [1]. Our pharmacists are available on (+44) 116 4646009 during business hours to discuss any concerns, and we provide 24/7 access to NHS 111 guidance for urgent queries outside operating hours.

Long-Term Treatment Considerations

Wegovy is intended for chronic weight management, meaning ongoing treatment is typically required to maintain weight loss [2]. Clinical trials showed that patients who discontinued semaglutide regained approximately two-thirds of lost weight within one year [5]. Your prescriber will discuss realistic expectations about treatment duration and strategies for transitioning to weight maintenance, including continued lifestyle modifications and potential for intermittent dosing protocols under medical supervision.

Scientific References

1. Electronic Medicines Compendium. (2023). Wegovy 2.4 mg solution for injection in pre-filled pen - Summary of Product Characteristics. https://www.medicines.org.uk/emc/product/13799 [accessed 13 August 2026]
2. Wilding, J. P. H., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
3. Müller, T. D., et al. (2019). Glucagon-like peptide 1 (GLP-1). Molecular Metabolism, 30, 72–130. https://doi.org/10.1016/j.molmet.2019.09.010 [accessed 13 August 2026]
4. National Institute for Health and Care Excellence. (2023). Semaglutide for managing overweight and obesity. Technology appraisal guidance [TA875]. https://www.nice.org.uk/guidance/ta875 [accessed 13 August 2026]
5. Rubino, D., et al. (2021). Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial. JAMA, 325(14), 1414–1425. https://doi.org/10.1001/jama.2021.3224 [accessed 13 August 2026]
6. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
7. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
8. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Individual results may vary, and weight loss outcomes depend on adherence to prescribed treatment and lifestyle modifications.